Literature DB >> 21977172

Extra-articular Manifestations in Rheumatoid Arthritis.

Manole Cojocaru1, Inimioara Mihaela Cojocaru, Isabela Silosi, Camelia Doina Vrabie, R Tanasescu.   

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease whose main characteristic is persistent joint inflammation that results in joint damage and loss of function.Although RA is more common in females, extra-articular manifestations of the disease are more common in males. The extra-articular manifestations of RA can occur at any age after onset. It is characterised by destructive polyarthritis and extra-articular organ involvement, including the skin, eye, heart, lung, renal, nervous and gastrointestinal systems. The frequence of extra-articular manifestations in RA differs from one country to another. Extra-articular organ involvement in RA is more frequently seen in patients with severe, active disease and is associated with increased mortality. Incidence and frequence figures for extra-articular RA vary according to study design. Extra-articular involvement is more likely in those who have RF and/or are HLA-DR4 positive. Occasionally, there are also systemic manifestations such as vasculitis, visceral nodules, Sjögren's syndrome, or pulmonary fibrosis present. Nodules are the most common extra-articular feature, and are present in up to 30%; many of the other classic features occur in 1% or less in normal clinic settings. Sjögren's syndrome, anaemia of chronic disease and pulmonary manifestations are relatively common - in 6-10%, are frequently present in early disease and are all related to worse outcomes measures of rheumatoid disease in particular functional impairment and mortality. The occurrence of these systemic manifestations is a major predictor of mortality in patients with RA.This paper focuses on extra-articular manifestations, defined as diseases and symptoms not directly related to the locomotor system.

Entities:  

Keywords:  extra-articular manifestations; rheumatoid arthritis

Year:  2010        PMID: 21977172      PMCID: PMC3152850     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  54 in total

Review 1.  Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

Authors:  S Van Doornum; G McColl; I P Wicks
Journal:  Arthritis Rheum       Date:  2002-04

2.  Asymptomatic pulmonary involvement in RA.

Authors:  G Provenzano
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

3.  Clustering of extraarticular manifestations in patients with rheumatoid arthritis.

Authors:  Carl Turesson; Robyn L McClelland; Teresa Christianson; Eric Matteson
Journal:  J Rheumatol       Date:  2008-01       Impact factor: 4.666

4.  Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis.

Authors:  A McEntegart; H A Capell; D Creran; A Rumley; M Woodward; G D Lowe
Journal:  Rheumatology (Oxford)       Date:  2001-06       Impact factor: 7.580

5.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

6.  Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis.

Authors:  Oscar-Danilo Ortega-Hernandez; Ricardo Pineda-Tamayo; Aryce L Pardo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Clin Rheumatol       Date:  2009-03-10       Impact factor: 2.980

7.  The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006.

Authors:  Marc C Hochberg; Stephen S Johnston; Ani K John
Journal:  Curr Med Res Opin       Date:  2008-02       Impact factor: 2.580

8.  Extra-articular manifestations.

Authors:  H Mielants; F Van den Bosch
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

9.  Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity.

Authors:  L Carmona; I González-Alvaro; A Balsa; M Angel Belmonte; X Tena; R Sanmartí
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

10.  Unusual haematological alterations in rheumatoid arthritis.

Authors:  V Agarwal; A Sachdev; S Lehl; S Basu
Journal:  J Postgrad Med       Date:  2004 Jan-Mar       Impact factor: 1.476

View more
  67 in total

1.  An assessment of ocular elasticity using real time ultrasound and ocular response analyzer in active or remission rheumatoid arthritis.

Authors:  Mehmet Erol Can; Özlem Unal; Meltem Ece Kars; Sukran Erten; Gamze Dereli Can; Necati Duru; Nurullah Cagil
Journal:  Int Ophthalmol       Date:  2018-12-03       Impact factor: 2.031

2.  Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis.

Authors:  Bonnie Williams; Eleni Tsangari; Romany Stansborough; Victor Marino; Melissa Cantley; Anak Dharmapatni; Rachel Gibson; Egon Perilli; Tania Crotti
Journal:  Inflammopharmacology       Date:  2017-01-03       Impact factor: 4.473

Review 3.  The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases.

Authors:  A Mohr; M Atif; R Balderas; G Gorochov; M Miyara
Journal:  Clin Exp Immunol       Date:  2019-03-24       Impact factor: 4.330

4.  Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset.

Authors:  Jesse M Damsker; Michaelyn R Cornish; Priya Kanneboyina; Ila Kanneboyina; Qing Yu; Rachel Lipson; Aditi Phadke; Susan M Knoblach; Karuna Panchapakesan; Melissa Morales; Alyson A Fiorillo; Terence Partridge; Kanneboyina Nagaraju
Journal:  Inflamm Res       Date:  2019-08-24       Impact factor: 4.575

5.  Anti-inflammatory and antioxidant effect of Kerabala: a value-added ayurvedic formulation from virgin coconut oil inhibits pathogenesis in adjuvant-induced arthritis.

Authors:  M Ratheesh; S Sandya; C Pramod; S Asha; Jose P Svenia; S Premlal; B GrishKumar
Journal:  Inflammopharmacology       Date:  2016-11-22       Impact factor: 4.473

Review 6.  Should ultrasound be used routinely in the diagnosis of rheumatoid arthritis?

Authors:  Maria Boylan
Journal:  Ir J Med Sci       Date:  2019-10-23       Impact factor: 1.568

Review 7.  Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis.

Authors:  Josefina Gutiérrez; Hugo Sandoval; Iván Pérez-Neri; Antonio Arauz; Juan Carlos López-Hernández; Carlos Pineda
Journal:  Rheumatol Int       Date:  2021-01-11       Impact factor: 2.631

8.  Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa.

Authors:  Nericke Olivier; Johanita Burger; Rianda Joubert; Martie Lubbe; Adele Naudé; Marike Cockeran
Journal:  Rheumatol Int       Date:  2017-12-12       Impact factor: 2.631

Review 9.  Methotrexate revisited: considerations for subcutaneous administration in RA.

Authors:  Randy Jay
Journal:  Clin Rheumatol       Date:  2014-11-30       Impact factor: 2.980

10.  Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice.

Authors:  Tal Gazitt; Shirley Oren; Tatiana Reitblat; Merav Lidar; Alexandra Balbir Gurman; Itzhak Rosner; Nimer Halabe; Joy Feld; Sameer Kassem; Idit Lavi; Ori Elkayam; Devy Zisman
Journal:  Eur J Rheumatol       Date:  2019-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.